|
市場調查報告書
豬流感市場警戒（最新資料、企業簡介、免疫測定以及分子檢查）
H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)
|
豬流感市場警戒（最新資料、企業簡介、免疫測定以及分子檢查） 是由出版商Kalorama Information在2009年05月所出版的。
這份英文市場調查報告書包含60 pages 價格從美金800起跳。
此報告書內容交織著免疫測定以及分子檢查市場動向、H1N1型病毒概要、已上市產品動向、相同領域的25家製造業者簡介等。報告書之內容摘要如下所示。
第1章 摘要
第2章 豬流感與其他流感
- 流感概要
- 病毒種類
- 這次的流感為什麼那麼特別呢
- 流感的治療
- WHO對於全球流感的應對計畫
第3章 流感診斷
- 背景
- 免疫測定
- 即時檢查
- 即時檢查的市場實績
- 新投入的可行性
- 結論：即時檢查對豬流感的影響
- 分子檢查
- 分子探測技術
- PCR檢查
- 教訓與對H5N1型流感市場的影響
第4章 A/H1N1型的癒後診斷
- 背景
- 感染：在哪裡、什麼時候
- 1976年的Hsw1N1豬流感發病例
- 過去的感染與2009年的比較
- 全球的反應
- 豬流感與IVD業界
- 流感病毒混和
- PCR檢查開發
- 近年的畫時代研究開發
- 在目前的感染狀況中使用即時檢查
第5章 受到豬流感影響的企業與產品
- 免疫測定
- 3M Medical Diagnostics
- Becton, Dickinson and Company
- Genzyme Corporation
- Inverness Medical Innovations
- Meridian Bioscience, Inc.
- Quidel Corporation
- Remel, Inc.
- Response Biomedical Corporation
- 分子檢查
- Arbor Vita Corporation
- CombiMatrix Molecular Diagnostics
- Diagnostic HYBRIDS, Inc.
- eGene Inc.
- Eiken Chemical Co., Ltd.
- Life Technologies/Applied biosystems/Invitrogen Corporation
- Lab21
- laboratory Corporation of America Holdings
- Luminex Corporation
- Nanogen
- Prodesse Inc.
- Qiagen N.V.
- Seegene Inc.
- Veredus Laboratories Pte
Abstract
The outbreak of swine flu is highlighting the public health importance of
improved testing techniques and providing market opportunities for
manufacturers of diagnostic tests and other products related to the disease.
These conclusions and others appear in a new report released from Kalorama
Information: Swine Flu Market Alert by Kalorama' s lead analyst, Shara Rosen.
Regardless of the eventual severity of the epidemic, there will be distinct
market impact on both immunoassay and molecular test makers, according to the
report. The makers of certain tests will benefit both in terms of sales and
more broadly in recognition that their products play a vital role in making
the public health community significantly better prepared for this possible
pandemic than 1968 or before.
The report examines:
- Market Impact likely for immunoassays and molecular testing.
- Lessons from previous epidemics, likely impact on both immunoassays and
molecular testing.
- Overview of the H1N1 strain as compared to other.
- Immunoassay and Molecular Test Products Available on the Market
- Developments in the last few days of significance to the diagnostic
industry.
- Profiles of nearly 25 specific manufacturers active in this space.
The report focuses almost exclusively on the in vitro diagnostic industry as
it applies to work being done by commercial entities and products that are
either in development or have been brought to market.
The market assessment provided has been assembled based on publicly available
information. Company sales data and other quantitative evaluations of the
markets for flu diagnostics have been developed based on publicly available
information and are expressed in US dollars, no adjustments have been made for
currency exchange fluctuations.
Under normal circumstances, a report of this genre would be assembled from
information derived from primary and secondary sources. However, in the short
time it took to research and write this report, almost all of the major
scientific and industry experts were occupied with the extraordinary task of
preparing for a pandemic.
Therefore the information contained in this report has been assembled from a
vast array of scientific and market publications, government sources, analyzed
by a professional analyst.
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Background
- Exhibit 1: Flu Epidemics Compared to Present 1918-Today
- Scope And Methodology
- Point of View
- Information Sources
CHAPTER TWO: 2009 SWINE INFLUENZA AND OTHER FLU EPIDEMICS
- Influenza Overview
- Overview of Virus Types
- What' s So Special About This Latest Flu?
- Flu Therapeutics
- WHO Global Influenza Preparedness Plan
CHAPTER THREE: FLU DIAGNOSTICS
- Background
- Exhbit 2: Influenza Test Innovations, 2009 (Company, Technology, Test
Details, Status)
- Immunoassays
- Rapid Testing
- Market Performance of Rapid Test
- New Entrant Possiblity
- Conclusion: Impact of Swine Flu on Rapid Testing
- Molecular Assays
- Molecular Influenza Detection Techniques
- PCR, Sequencing or Both
- Lessons and Market Impact of the H5N1 Epidemic
CHAPTER FOUR: PROGNOSIS FOR A/H1N1
- Background
- Pandemic - Where? When?
- 1976 Hsw1N1 Swine Flu Case
- Comparing Past Flu Epidemics to 2009
- International Reaction
- Swine Flu and the IVD Industry
- Origin of Flu Virus Mixes
- PCR Test Development
- Late-Breaking Research Developments
- Use of Rapid Tests in Current Epidemic
CHAPTER FIVE: COMPANIES AND PRODCUTS IMPACTED BY SWINE FLU EPIDEMIC
- Immunoassays
- 3M Medical Diagnostics
- Becton, Dickinson and Company (BD)
- Genzyme Corporation
- Inverness Medical Innovations
- Meridian Bioscience, Inc.
- Quidel Corporation
- Remel, Inc.
- Response Biomedical Corporation
- Molecular Tests
- Arbor Vita Corporation
- CombiMatrix Molecular Diagnostics (CMDX)
- Diagnostic HYBRIDS, Inc. (DHI)
- eGene Inc.
- Eiken Chemical Co., Ltd
- Life Technologies/Applied Biosystems/ Invitrogen Corporation (ABI)
- Lab21
- Laboratory Corporation of America Holdings (LabCorp)
- Luminex Corporation
- Nanogen
- Prodesse Inc.
- Qiagen N.V.
- Seegene Inc.
- Veredus Laboratories Pte
|
